These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24330851)

  • 1. Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.
    Yang J; Ouyang J; Ouyang L; Ouyang L; Chen Y
    Oncol Res; 2013; 21(1):43-50. PubMed ID: 24330851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
    Jiang C; Yi XP; Shen H; Li YX
    World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus-mediated shRNA targeting XIAP and survivin inhibit SW1990 pancreatic cancer cell proliferation in vitro and in vivo.
    Jiang C; Tan T; Yi XP; Shen H; Li YX
    Mol Med Rep; 2011; 4(4):667-74. PubMed ID: 21479361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [X-linked inhibitor of apoptosis protein (XIAP) and Survivin suppression on human pancreatic cancer cells Panc-1 proliferation and chemosensitivety].
    Zai HY; Yi XP; Li YX; You XY; Cao LP; Liu H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):242-9. PubMed ID: 23591345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway.
    Yi XP; Han T; Li YX; Long XY; Li WZ
    Mol Med Rep; 2015 Jul; 12(1):601-8. PubMed ID: 25707849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.
    Galloway NR; Aspe JR; Sellers C; Wall NR
    Pancreas; 2009 Oct; 38(7):782-90. PubMed ID: 19506533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
    Guo HC; Bu HQ; Luo J; Wei WT; Liu DL; Chen H; Tong HF; Wang ZH; Wu HY; Li HH; Zuo MM; Li W; Lin SZ
    Int J Oncol; 2012 Jun; 40(6):1849-57. PubMed ID: 22378302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells.
    Shrikhande SV; Kleeff J; Kayed H; Keleg S; Reiser C; Giese T; Büchler MW; Esposito I; Friess H
    Anticancer Res; 2006; 26(5A):3265-73. PubMed ID: 17094439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression.
    Fei B; Chi AL; Weng Y
    World J Surg Oncol; 2013 May; 11():120. PubMed ID: 23721525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
    Dizdar L; Oesterwind KA; Riemer JC; Werner TA; Mersch S; Möhlendick B; Schütte SC; Verde PE; Raba K; Topp SA; Stoecklein NH; Esposito I; Knoefel WT; Krieg A
    Oncotarget; 2017 Jan; 8(5):8369-8382. PubMed ID: 28039474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells.
    Kawanami T; Takiguchi S; Ikeda N; Funakoshi A
    Oncol Rep; 2012 Mar; 27(3):867-72. PubMed ID: 22200743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XIAP is related to the chemoresistance and inhibited its expression by RNA interference sensitize pancreatic carcinoma cells to chemotherapeutics.
    Li Y; Jian Z; Xia K; Li X; Lv X; Pei H; Chen Z; Li J
    Pancreas; 2006 Apr; 32(3):288-96. PubMed ID: 16628085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.
    Karikari CA; Roy I; Tryggestad E; Feldmann G; Pinilla C; Welsh K; Reed JC; Armour EP; Wong J; Herman J; Rakheja D; Maitra A
    Mol Cancer Ther; 2007 Mar; 6(3):957-66. PubMed ID: 17339366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.
    Singla S; Pippin JA; Drebin JA
    Oncol Rep; 2012 Dec; 28(6):2211-6. PubMed ID: 23007710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Cao LP; Song JL; Yi XP; Li YX
    Oncol Rep; 2013 Apr; 29(4):1659-65. PubMed ID: 23354694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.
    Liu WS; Yan HJ; Qin RY; Tian R; Wang M; Jiang JX; Shen M; Shi CJ
    Dig Dis Sci; 2009 Jan; 54(1):89-96. PubMed ID: 18594980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis.
    Rückert F; Samm N; Lehner AK; Saeger HD; Grützmann R; Pilarsky C
    BMC Cancer; 2010 Jul; 10():379. PubMed ID: 20646298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.